HER2-targeted ADC binds HER2, is internalized, and releases a camptothecin-derived topoisomerase I inhibitor that causes DNA damage, replication arrest, and apoptosis in HER2-expressing cells; IgG1 Fc may also mediate ADCC and bystander killing.